VALPROATE SODIUM

VALPROATE SODIUM was reported 21029 times

VALPROATE SODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FOETAL VALPROATE SYNDROME 46 0.4600
1 EAR, NOSE AND THROAT DISORDER 61 0.4326
2 HYPERTELORISM 42 0.4242
3 ARACHNODACTYLY 23 0.3594
4 FOETAL ANTICONVULSANT SYNDROME 364 0.3069
5 PROGNATHISM 26 0.2766
6 SOCIAL (PRAGMATIC) COMMUNICATION DISORDER 18 0.2609
7 DEVELOPMENTAL COORDINATION DISORDER 48 0.2567
8 CAMPTODACTYLY CONGENITAL 19 0.2500
9 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 147 0.2127
10 NEOVASCULARISATION 55 0.2091
11 PECTUS EXCAVATUM 38 0.1872
12 CONGENITAL EYELID MALFORMATION 24 0.1860
13 JOINT LAXITY 53 0.1755
14 LIGAMENT LAXITY 25 0.1712
15 DYSMORPHISM 389 0.1650
16 CEREBRAL SALT-WASTING SYNDROME 16 0.1616
17 CONGENITAL ORAL MALFORMATION 31 0.1416
18 TOOTH MALFORMATION 23 0.1329
19 CONGENITAL NOSE MALFORMATION 68 0.1278
20 CONGENITAL FOOT MALFORMATION 58 0.1278
21 FACIAL DYSMORPHISM 28 0.1267
22 PROMINENT EPICANTHAL FOLDS 17 0.1206
23 PRODUCT ADMINISTRATION ISSUE 25 0.1196
24 ENCOPRESIS 23 0.1186
25 DYSPRAXIA 66 0.1170
26 CLINODACTYLY 32 0.1164
27 SPEECH SOUND DISORDER 20 0.1163
28 BONE MARROW TRANSPLANT REJECTION 25 0.1136
29 DYSCALCULIA 27 0.1093
30 RETINOGRAM ABNORMAL 29 0.1082
31 CONGENITAL GENITAL MALFORMATION 17 0.1062
32 LEARNING DISORDER 246 0.1019
33 CONGENITAL HAND MALFORMATION 68 0.0993
34 FINE MOTOR DELAY 25 0.0984
35 HYPERMOBILITY SYNDROME 49 0.0984
36 ECHOLALIA 31 0.0975
37 INTELLECTUAL DISABILITY 148 0.0974
38 SINUS RHYTHM 42 0.0963
39 REBOUND PSYCHOSIS 20 0.0939
40 LOW SET EARS 38 0.0925
41 LANGUAGE DISORDER 199 0.0920
42 MOTOR DEVELOPMENTAL DELAY 52 0.0900
43 SUDDEN UNEXPLAINED DEATH IN EPILEPSY 47 0.0879
44 DISINHIBITION 140 0.0869
45 LIMB MALFORMATION 67 0.0849
46 SKULL MALFORMATION 52 0.0809
47 SPEECH DISORDER DEVELOPMENTAL 223 0.0777
48 GROSS MOTOR DELAY 22 0.0775
49 EPILEPTIC ENCEPHALOPATHY 17 0.0762
50 PSYCHOMOTOR SKILLS IMPAIRED 197 0.0751
51 LORDOSIS 26 0.0741
52 SCHIZOAFFECTIVE DISORDER 130 0.0728
53 PLAGIOCEPHALY 36 0.0721
54 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 27 0.0711
55 NEURODEVELOPMENTAL DISORDER 47 0.0695
56 HYPERTELORISM OF ORBIT 28 0.0670
57 PSYCHOMOTOR RETARDATION 186 0.0661
58 WRONG PATIENT 33 0.0657
59 PERSONAL RELATIONSHIP ISSUE 43 0.0643
60 SPINE MALFORMATION 22 0.0634
61 HYPERAMMONAEMIA 317 0.0633
62 HYPERAMMONAEMIC ENCEPHALOPATHY 107 0.0615
63 CONSCIOUSNESS FLUCTUATING 62 0.0594
64 EXECUTIVE DYSFUNCTION 32 0.0590
65 EAR MALFORMATION 26 0.0562
66 SPASMODIC DYSPHONIA 17 0.0561
67 DELUSION OF GRANDEUR 25 0.0557
68 MUSCLE TONE DISORDER 17 0.0545
69 HYPERMETROPIA 49 0.0515
70 NOSE DEFORMITY 19 0.0511
71 ASTIGMATISM 77 0.0508
72 CRYPTORCHISM 56 0.0499
73 IMPAIRED REASONING 19 0.0497
74 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 37 0.0491
75 JOINT HYPEREXTENSION 19 0.0487
76 BEHAVIOUR DISORDER 261 0.0482
77 AUTISM SPECTRUM DISORDER 258 0.0468
78 MACROCEPHALY 18 0.0464
79 ELECTROENCEPHALOGRAM ABNORMAL 145 0.0459
80 WRONG PATIENT RECEIVED PRODUCT 133 0.0454
81 ANTICONVULSANT DRUG LEVEL INCREASED 73 0.0452
82 MENINGOMYELOCELE 27 0.0450
83 HYPOSPADIAS 93 0.0447
84 ANTIPSYCHOTIC DRUG LEVEL INCREASED 125 0.0444
85 DYSLEXIA 50 0.0434
86 STEREOTYPY 40 0.0424
87 EDUCATIONAL PROBLEM 70 0.0421
88 MEDICATION OVERUSE HEADACHE 35 0.0409
89 STRABISMUS 120 0.0408
90 INFANTILE SPASMS 29 0.0401
91 ANTIPSYCHOTIC DRUG LEVEL DECREASED 21 0.0395
92 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 35 0.0393
93 ARNOLD-CHIARI MALFORMATION 36 0.0377
94 ASTERIXIS 40 0.0376
95 ANTICONVULSANT DRUG LEVEL DECREASED 53 0.0375
96 PRESSURE OF SPEECH 24 0.0369
97 GRANULOCYTOPENIA 205 0.0360
98 CRANIOSYNOSTOSIS 31 0.0358
99 MULTIPLE-DRUG RESISTANCE 111 0.0358
100 PSYCHIATRIC DECOMPENSATION 65 0.0332
101 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 17 0.0325
102 MYOCLONIC EPILEPSY 49 0.0323
103 DEVELOPMENTAL DELAY 287 0.0318
104 KNEE DEFORMITY 47 0.0316
105 FANCONI SYNDROME 44 0.0311
106 MYOPIA 74 0.0311
107 HIRSUTISM 41 0.0308
108 SPINA BIFIDA 63 0.0302
109 HYPOTONIA NEONATAL 47 0.0301
110 STATUS EPILEPTICUS 337 0.0298
111 MICROCEPHALY 38 0.0296
112 ATONIC SEIZURES 25 0.0291
113 PETIT MAL EPILEPSY 148 0.0290
114 THERAPEUTIC PRODUCT EFFECT VARIABLE 112 0.0288
115 EPILEPSY 869 0.0284
116 CEREBELLAR ATROPHY 25 0.0284
117 OCULOGYRIC CRISIS 60 0.0279
118 FINE MOTOR SKILL DYSFUNCTION 80 0.0276
119 COMMUNICATION DISORDER 105 0.0274
120 LIP EROSION 20 0.0274
121 AMBLYOPIA 16 0.0271
122 BICUSPID AORTIC VALVE 16 0.0269
123 TONIC CONVULSION 38 0.0268
124 DRUG CLEARANCE DECREASED 35 0.0268
125 DYSMETRIA 16 0.0265
126 MULTIPLE CONGENITAL ABNORMALITIES 38 0.0264
127 ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC 17 0.0262
128 CEREBRAL VENTRICLE DILATATION 30 0.0260
129 ORAL MUCOSA EROSION 32 0.0260
130 ENURESIS 105 0.0260
131 TALIPES 80 0.0257
132 BLOOD OSMOLARITY DECREASED 16 0.0256
133 SEIZURE CLUSTER 21 0.0253
134 ANOSOGNOSIA 19 0.0247
135 PLEUROTHOTONUS 22 0.0243
136 DIFFERENTIAL WHITE BLOOD CELL COUNT ABNORMAL 40 0.0236
137 NASAL DISORDER 62 0.0233
138 ATTENTION DEFICIT HYPERACTIVITY DISORDER 98 0.0233
139 OTITIS MEDIA ACUTE 17 0.0231
140 PSYCHOTIC SYMPTOM 47 0.0227
141 OBSESSIVE-COMPULSIVE DISORDER 180 0.0224
142 LIP DISORDER 42 0.0222
143 TROPONIN T INCREASED 28 0.0221
144 DISTURBANCE IN SOCIAL BEHAVIOUR 52 0.0221
145 CROUP INFECTIOUS 17 0.0216
146 PERSECUTORY DELUSION 53 0.0212
147 PARTIAL SEIZURES 109 0.0208
148 CLEFT PALATE 40 0.0207
149 AMMONIA INCREASED 104 0.0204
150 KYPHOSIS 36 0.0204
151 DYSGRAPHIA 134 0.0203
152 BRUGADA SYNDROME 21 0.0203
153 HYPOTONIA 202 0.0202
154 BIPOLAR I DISORDER 44 0.0200
155 AUTISM 20 0.0197
156 SOPOR 261 0.0197
157 GAZE PALSY 33 0.0194
158 NEUROLEPTIC MALIGNANT SYNDROME 229 0.0193
159 HYDROCELE 20 0.0188
160 HYPORESPONSIVE TO STIMULI 22 0.0187
161 MUCOSAL EROSION 17 0.0187
162 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 60 0.0185
163 FOCAL DYSCOGNITIVE SEIZURES 21 0.0184
164 NEPHROGENIC DIABETES INSIPIDUS 21 0.0182
165 FEBRILE CONVULSION 22 0.0180
166 ANTISOCIAL BEHAVIOUR 18 0.0180
167 SCOLIOSIS 109 0.0176
168 SOMATIC SYMPTOM DISORDER 19 0.0176
169 APRAXIA 26 0.0175
170 SCHIZOPHRENIA 212 0.0174
171 HYPOMANIA 64 0.0174
172 PARADOXICAL DRUG REACTION 64 0.0174
173 COMA SCALE ABNORMAL 50 0.0172
174 PERSONALITY DISORDER 45 0.0172
175 COGWHEEL RIGIDITY 18 0.0171
176 DYSLIPIDAEMIA 87 0.0171
177 COMPLEX PARTIAL SEIZURES 19 0.0171
178 DEPRESSIVE SYMPTOM 59 0.0167
179 OTITIS MEDIA 55 0.0166
180 BRONCHIAL HYPERREACTIVITY 20 0.0166
181 CEREBRAL ATROPHY 66 0.0165
182 MUTISM 24 0.0165
183 HYPERNATRAEMIA 82 0.0164
184 POLYDACTYLY 19 0.0164
185 GRAND MAL CONVULSION 151 0.0163
186 PARKINSONISM 156 0.0160
187 CATATONIA 84 0.0160
188 JUDGEMENT IMPAIRED 23 0.0158
189 READING DISORDER 36 0.0157
190 AUDITORY DISORDER 22 0.0155
191 EUPHORIC MOOD 157 0.0153
192 BLOOD UREA DECREASED 19 0.0153
193 BONE MARROW TRANSPLANT 29 0.0153
194 AKATHISIA 208 0.0152
195 IMPULSIVE BEHAVIOUR 57 0.0152
196 EAR DISORDER 69 0.0151
197 MONOCYTE COUNT INCREASED 54 0.0149
198 BRONCHIOLITIS 52 0.0148
199 AUTONOMIC NERVOUS SYSTEM IMBALANCE 43 0.0147
200 ATAXIA 172 0.0145
201 TROPONIN INCREASED 109 0.0143
202 DEPRESSION SUICIDAL 49 0.0141
203 VASOPLEGIA SYNDROME 23 0.0140
204 CHOREA 24 0.0139
205 DRUG LEVEL DECREASED 138 0.0135
206 TEARFULNESS 58 0.0135
207 ALCOHOL ABUSE 36 0.0134
208 METABOLIC SYNDROME 22 0.0134
209 MUSCLE CONTRACTURE 27 0.0133
210 HEART DISEASE CONGENITAL 47 0.0133
211 LYMPHOCYTE COUNT INCREASED 43 0.0132
212 NEUTROPHIL COUNT INCREASED 134 0.0131
213 FOETAL EXPOSURE DURING PREGNANCY 1053 0.0129
214 HYPERTONIA 74 0.0129
215 MYOCARDITIS 147 0.0128
216 GENERALISED TONIC-CLONIC SEIZURE 212 0.0128
217 SALIVARY HYPERSECRETION 128 0.0128
218 INTESTINAL DILATATION 17 0.0127
219 ANION GAP INCREASED 17 0.0127
220 MANIA 209 0.0127
221 CONGENITAL ANOMALY 98 0.0126
222 GROWTH RETARDATION 37 0.0126
223 AKINESIA 26 0.0125
224 GINGIVAL HYPERTROPHY 19 0.0125
225 LABELLED DRUG-DRUG INTERACTION ISSUE 18 0.0124
226 DRUG WITHDRAWAL CONVULSIONS 22 0.0124
227 BICYTOPENIA 24 0.0122
228 ELECTROCARDIOGRAM T WAVE ABNORMAL 19 0.0122
229 MYOCLONUS 145 0.0121
230 HAEMANGIOMA 28 0.0121
231 MEGACOLON 19 0.0121
232 LEARNING DISABILITY 63 0.0118
233 PHARYNGEAL DISORDER 34 0.0118
234 TORTICOLLIS 25 0.0118
235 SEDATION COMPLICATION 30 0.0117
236 POLYCYSTIC OVARIES 18 0.0116
237 DRUG LEVEL INCREASED 191 0.0115
238 NYSTAGMUS 61 0.0115
239 FOOT DEFORMITY 125 0.0113
240 PSYCHOTIC DISORDER 331 0.0112
241 RUBBER SENSITIVITY 17 0.0111
242 POTENTIATING DRUG INTERACTION 37 0.0110
243 HYPERTHERMIA MALIGNANT 16 0.0107
244 ALTERED STATE OF CONSCIOUSNESS 233 0.0107
245 PSYCHOMOTOR HYPERACTIVITY 178 0.0107
246 CONVULSION 612 0.0107
247 INGUINAL HERNIA 65 0.0107
248 POSTURE ABNORMAL 34 0.0104
249 BLOOD PHOSPHORUS DECREASED 38 0.0104
250 METABOLIC ENCEPHALOPATHY 31 0.0103
251 MULTIPLE DRUG OVERDOSE INTENTIONAL 33 0.0103
252 EXTRAPYRAMIDAL DISORDER 254 0.0102
253 THERAPEUTIC AGENT TOXICITY 34 0.0102
254 ACUTE GRAFT VERSUS HOST DISEASE 46 0.0100
255 DEAFNESS BILATERAL 17 0.0100
256 ENCEPHALOPATHY 245 0.0100
257 BREAST DISORDER 20 0.0098
258 HOMICIDE 18 0.0098
259 HYPERLACTACIDAEMIA 26 0.0097
260 EOSINOPHIL COUNT DECREASED 23 0.0097
261 CONJUNCTIVAL HYPERAEMIA 34 0.0095
262 BLOOD BICARBONATE DECREASED 18 0.0095
263 STUPOR 30 0.0093
264 SEDATION 244 0.0093
265 HALLUCINATION, AUDITORY 148 0.0093
266 DISORGANISED SPEECH 17 0.0092
267 HYPERTHERMIA 70 0.0092
268 CARDIAC MURMUR 78 0.0090
269 PNEUMONIA ASPIRATION 225 0.0090
270 TEMPERATURE REGULATION DISORDER 20 0.0090
271 HYPOPROTEINAEMIA 17 0.0090
272 MUSCLE RIGIDITY 107 0.0089
273 HEPATIC FUNCTION ABNORMAL 333 0.0089
274 HYPERACUSIS 33 0.0089
275 PSYCHIATRIC SYMPTOM 65 0.0088
276 DELUSION 136 0.0087
277 INCREASED APPETITE 167 0.0087
278 VENTRICULAR SEPTAL DEFECT 50 0.0087
279 DIABETES INSIPIDUS 21 0.0087
280 PHYSICAL ASSAULT 18 0.0086
281 INTENTIONAL SELF-INJURY 174 0.0086
282 OBESITY 137 0.0086
283 AGGRESSION 429 0.0086
284 DRUG INTERACTION 1334 0.0084
285 FAECALOMA 46 0.0084
286 SELF-INJURIOUS IDEATION 35 0.0083
287 RENAL TUBULAR ACIDOSIS 18 0.0082
288 COMA 392 0.0082
289 BRADYKINESIA 48 0.0081
290 DEPRESSED LEVEL OF CONSCIOUSNESS 319 0.0081
291 PARANOIA 139 0.0081
292 LEUKAEMIA 76 0.0080
293 HYPERREFLEXIA 28 0.0080
294 ANURIA 68 0.0079
295 DRUG LEVEL ABOVE THERAPEUTIC 36 0.0079
296 STRIDOR 23 0.0078
297 DRUG LEVEL BELOW THERAPEUTIC 43 0.0078
298 BRADYPNOEA 21 0.0078
299 RESPIRATORY DEPRESSION 95 0.0077
300 TOXIC ENCEPHALOPATHY 39 0.0077
301 CLONUS 21 0.0077
302 ATRIAL SEPTAL DEFECT 64 0.0076
303 SUICIDE ATTEMPT 461 0.0076
304 PATENT DUCTUS ARTERIOSUS 30 0.0075
305 PRESCRIBED OVERDOSE 146 0.0075
306 BIPOLAR DISORDER 82 0.0075
307 SELF INJURIOUS BEHAVIOUR 23 0.0075
308 COGNITIVE DISORDER 352 0.0075
309 ANXIETY DISORDER 25 0.0075
310 SOCIAL AVOIDANT BEHAVIOUR 43 0.0074
311 STEVENS-JOHNSON SYNDROME 164 0.0074
312 ANOREXIA 95 0.0074
313 HYPOTHERMIA 74 0.0073
314 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 75 0.0073
315 LIVE BIRTH 61 0.0073
316 REGURGITATION 25 0.0073
317 SOCIAL PROBLEM 30 0.0072
318 RED CELL DISTRIBUTION WIDTH INCREASED 30 0.0072
319 STEM CELL TRANSPLANT 18 0.0072
320 GASTROINTESTINAL NECROSIS 21 0.0072
321 TOXIC EPIDERMAL NECROLYSIS 109 0.0072
322 MATERNAL DRUGS AFFECTING FOETUS 55 0.0072
323 COORDINATION ABNORMAL 100 0.0072
324 STAPHYLOCOCCAL SEPSIS 35 0.0071
325 SEIZURE 818 0.0071
326 HEPATITIS FULMINANT 21 0.0071
327 BLOOD CREATINE PHOSPHOKINASE INCREASED 203 0.0070
328 MENTAL IMPAIRMENT 170 0.0070
329 GAMMA-GLUTAMYLTRANSFERASE INCREASED 153 0.0069
330 DISTURBANCE IN ATTENTION 372 0.0069
331 BRADYPHRENIA 45 0.0069
332 HYPERPYREXIA 29 0.0068
333 LEUKOPENIA 342 0.0068
334 POLYDIPSIA 27 0.0068
335 DROOLING 47 0.0068
336 ABORTION INDUCED 64 0.0068
337 HYPERPROLACTINAEMIA 44 0.0068
338 DRUG EXPOSURE DURING PREGNANCY 230 0.0068
339 BLOOD ALBUMIN DECREASED 53 0.0067
340 RESPIRATORY ACIDOSIS 26 0.0066
341 CLUMSINESS 18 0.0066
342 MOTOR DYSFUNCTION 67 0.0066
343 RHINITIS 53 0.0066
344 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 169 0.0066
345 VENTRICULAR ARRHYTHMIA 24 0.0066
346 TONSILLITIS 34 0.0065
347 URINE OUTPUT INCREASED 17 0.0065
348 BLOOD LACTIC ACID INCREASED 34 0.0064
349 STILLBIRTH 31 0.0064
350 DRUG TOXICITY 87 0.0064
351 EOSINOPHIL COUNT INCREASED 53 0.0064
352 EOSINOPHILIA 111 0.0063
353 NEUTROPHILIA 36 0.0063
354 BLOOD SODIUM INCREASED 17 0.0063
355 ATELECTASIS 60 0.0062
356 MEDICATION RESIDUE 16 0.0062
357 DRUG ERUPTION 109 0.0061
358 BLOOD PROLACTIN INCREASED 29 0.0061
359 DYSPHORIA 31 0.0061
360 POISONING DELIBERATE 58 0.0061
361 PROTEIN TOTAL DECREASED 23 0.0061
362 APATHY 88 0.0060
363 ABNORMAL BEHAVIOUR 239 0.0060
364 ANORGASMIA 16 0.0059
365 ELECTROCARDIOGRAM QT PROLONGED 211 0.0059
366 BRAIN OEDEMA 74 0.0059
367 AFFECTIVE DISORDER 46 0.0058
368 LEFT VENTRICULAR HYPERTROPHY 25 0.0058
369 SINUS BRADYCARDIA 56 0.0058
370 DELIRIUM 201 0.0058
371 PANCREATITIS ACUTE 130 0.0058
372 PRESCRIBED UNDERDOSE 114 0.0057
373 HYDROCEPHALUS 31 0.0057
374 LOGORRHOEA 20 0.0057
375 NEONATAL RESPIRATORY DISTRESS SYNDROME 20 0.0056
376 RHINITIS ALLERGIC 25 0.0056
377 INTENTIONAL OVERDOSE 360 0.0056
378 FOETAL GROWTH RESTRICTION 34 0.0056
379 FRUSTRATION TOLERANCE DECREASED 45 0.0056
380 DIFFICULTY IN WALKING 19 0.0055
381 DYSTONIA 107 0.0055
382 HEPATIC CYTOLYSIS 70 0.0055
383 DISORIENTATION 217 0.0055
384 WHITE BLOOD CELL COUNT INCREASED 210 0.0055
385 DYSPHEMIA 24 0.0055
386 LEUKOCYTOSIS 98 0.0054
387 AFFECT LABILITY 52 0.0054
388 JAUNDICE CHOLESTATIC 19 0.0054
389 ELECTROCARDIOGRAM ABNORMAL 42 0.0053
390 COAGULOPATHY 89 0.0053
391 HYPONATRAEMIA 300 0.0053
392 HALLUCINATIONS, MIXED 22 0.0052
393 PRIAPISM 18 0.0052
394 HYPOVENTILATION 17 0.0052
395 SEROTONIN SYNDROME 100 0.0052
396 C-REACTIVE PROTEIN INCREASED 189 0.0052
397 BRAIN DEATH 16 0.0052
398 ILEUS PARALYTIC 23 0.0051
399 AGRANULOCYTOSIS 95 0.0051
400 AGITATION 375 0.0051
401 TACHYPNOEA 69 0.0051
402 SOMNOLENCE 1017 0.0050
403 APHASIA 152 0.0050
404 DYSARTHRIA 188 0.0050
405 BRONCHOPNEUMONIA 17 0.0050
406 CYTOMEGALOVIRUS VIRAEMIA 22 0.0049
407 DRUG RESISTANCE 127 0.0049
408 APLASIA PURE RED CELL 17 0.0049
409 DRUG ABUSE 410 0.0049
410 THROMBOPHLEBITIS 17 0.0048
411 ERYTHEMA MULTIFORME 45 0.0048
412 BRUXISM 26 0.0048
413 EYE MOVEMENT DISORDER 33 0.0048
414 EAR INFECTION 128 0.0048
415 SINUS TACHYCARDIA 68 0.0048
416 HYPERPHAGIA 19 0.0048
417 TOXICITY TO VARIOUS AGENTS 802 0.0048
418 NEUTROPHIL COUNT DECREASED 193 0.0047
419 SUDDEN DEATH 50 0.0047
420 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 18 0.0047
421 CIRCULATORY COLLAPSE 80 0.0047
422 METABOLIC ACIDOSIS 150 0.0047
423 MENTAL DISORDER 202 0.0046
424 SMALL FOR DATES BABY 23 0.0046
425 BLOOD PRESSURE SYSTOLIC DECREASED 21 0.0046
426 TIC 25 0.0046
427 RASH MACULO-PAPULAR 100 0.0045
428 CARDIOMYOPATHY 66 0.0045
429 RESTLESSNESS 163 0.0044
430 HALLUCINATION, VISUAL 94 0.0044
431 FACIAL BONES FRACTURE 16 0.0044
432 LYMPHOCYTE COUNT DECREASED 78 0.0044
433 RHABDOMYOLYSIS 184 0.0044
434 GENERALISED ERYTHEMA 25 0.0044
435 DERMATITIS EXFOLIATIVE 22 0.0044
436 MAJOR DEPRESSION 32 0.0044
437 TACHYCARDIA 389 0.0044
438 OLIGURIA 27 0.0043
439 IRRITABILITY 261 0.0043
440 FINGER DEFORMITY 21 0.0043
441 LEFT VENTRICULAR DYSFUNCTION 29 0.0043
442 FEMORAL NECK FRACTURE 22 0.0043
443 TRICUSPID VALVE INCOMPETENCE 34 0.0043
444 BLOOD UREA INCREASED 71 0.0042
445 GESTATIONAL DIABETES 20 0.0042
446 HYPOTHYROIDISM 134 0.0042
447 ORTHOSTATIC HYPOTENSION 73 0.0042
448 ENCEPHALITIS 29 0.0042
449 INTESTINAL ISCHAEMIA 23 0.0042
450 THERAPY PARTIAL RESPONDER 65 0.0042
451 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 21 0.0041
452 PLATELET COUNT DECREASED 442 0.0041
453 WRONG PRODUCT ADMINISTERED 28 0.0041
454 SPEECH DISORDER 217 0.0041
455 HYPOKINESIA 60 0.0041
456 THROMBOCYTOPENIA 462 0.0041
457 HYPOALBUMINAEMIA 32 0.0041
458 OROPHARYNGEAL DISCOMFORT 37 0.0041
459 RESPIRATORY DISTRESS 113 0.0041
460 LIVER FUNCTION TEST ABNORMAL 119 0.0041
461 HEPATOMEGALY 40 0.0041
462 INCONTINENCE 43 0.0041
463 NEUTROPENIC SEPSIS 29 0.0041
464 ACUTE HEPATIC FAILURE 55 0.0040
465 COLITIS ISCHAEMIC 27 0.0040
466 NEUTROPENIA 544 0.0040
467 INTRACRANIAL PRESSURE INCREASED 22 0.0039
468 MITRAL VALVE INCOMPETENCE 44 0.0039
469 HEPATIC STEATOSIS 72 0.0039
470 FOETAL DEATH 20 0.0039
471 MULTIPLE DRUG OVERDOSE 19 0.0038
472 BLOOD ALKALINE PHOSPHATASE INCREASED 95 0.0038
473 UNRESPONSIVE TO STIMULI 98 0.0038
474 SARCOIDOSIS 18 0.0038
475 PHARYNGITIS 47 0.0038
476 URINARY INCONTINENCE 112 0.0038
477 LOW BIRTH WEIGHT BABY 30 0.0038
478 URINARY TRACT DISORDER 17 0.0038
479 TREATMENT NONCOMPLIANCE 206 0.0038
480 PLATELET COUNT INCREASED 49 0.0038
481 MENINGITIS 25 0.0037
482 MULTI-ORGAN FAILURE 64 0.0037
483 CEREBRAL ISCHAEMIA 19 0.0037
484 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 201 0.0037
485 VENOOCCLUSIVE LIVER DISEASE 18 0.0036
486 PETECHIAE 38 0.0036
487 CYANOSIS 57 0.0036
488 ASPIRATION 39 0.0036
489 IRON DEFICIENCY 16 0.0036
490 BLOOD LACTATE DEHYDROGENASE INCREASED 56 0.0035
491 DISSEMINATED INTRAVASCULAR COAGULATION 49 0.0035
492 ENTEROCOLITIS 20 0.0035
493 ASPARTATE AMINOTRANSFERASE INCREASED 184 0.0035
494 SCREAMING 22 0.0035
495 MALABSORPTION 18 0.0034
496 DYSKINESIA 140 0.0034
497 ATRIOVENTRICULAR BLOCK COMPLETE 23 0.0034
498 INTESTINAL OBSTRUCTION 128 0.0034
499 BLOOD TRIGLYCERIDES INCREASED 60 0.0034
500 EATING DISORDER 72 0.0034
501 OVERWEIGHT 18 0.0033
502 DERMATITIS ALLERGIC 42 0.0033
503 HAEMODIALYSIS 28 0.0033
504 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 25 0.0033
505 FAECAL INCONTINENCE 16 0.0033
506 HAEMATOCRIT DECREASED 66 0.0033
507 THINKING ABNORMAL 62 0.0033
508 SUBSTANCE ABUSE 27 0.0033
509 ASPHYXIA 27 0.0033
510 ALANINE AMINOTRANSFERASE INCREASED 203 0.0033
511 ILEUS 41 0.0033
512 BLOOD SODIUM DECREASED 62 0.0033
513 TRANSAMINASES INCREASED 73 0.0033
514 HYPERVENTILATION 19 0.0033
515 MYDRIASIS 42 0.0033
516 BLOOD BILIRUBIN INCREASED 88 0.0033
517 NASAL POLYPS 16 0.0032
518 DISABILITY 63 0.0032
519 TOXIC SKIN ERUPTION 32 0.0032
520 ANGER 107 0.0032
521 HYPERTRANSAMINASAEMIA 22 0.0032
522 ABORTION SPONTANEOUS 126 0.0031
523 CACHEXIA 16 0.0031
524 CAESAREAN SECTION 36 0.0031
525 APNOEA 24 0.0031
526 WHITE BLOOD CELL COUNT DECREASED 333 0.0031
527 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 218 0.0031
528 HEPATOTOXICITY 68 0.0031
529 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 27 0.0031
530 HEAD DISCOMFORT 54 0.0030
531 SOMNAMBULISM 20 0.0030
532 FOOD CRAVING 16 0.0030
533 MALNUTRITION 34 0.0030
534 LARGE INTESTINE PERFORATION 21 0.0030
535 HYPOXIA 106 0.0030
536 DIPLOPIA 78 0.0030
537 HEPATIC ENCEPHALOPATHY 28 0.0030
538 LIVER INJURY 73 0.0030
539 BRONCHIECTASIS 20 0.0030
540 LOSS OF CONSCIOUSNESS 379 0.0030
541 JOINT DISLOCATION 31 0.0029
542 HYPOKALAEMIA 135 0.0029
543 CONFUSIONAL STATE 472 0.0029
544 SUICIDAL IDEATION 267 0.0029
545 RED BLOOD CELL COUNT DECREASED 83 0.0029
546 ACIDOSIS 22 0.0029
547 POISONING 36 0.0029
548 PROTHROMBIN TIME PROLONGED 17 0.0028
549 HEPATOCELLULAR INJURY 40 0.0028
550 MOVEMENT DISORDER 90 0.0028
551 HYPERCHOLESTEROLAEMIA 27 0.0028
552 MUSCLE TWITCHING 64 0.0028
553 BRADYCARDIA 147 0.0028
554 MATERNAL EXPOSURE DURING PREGNANCY 246 0.0028
555 PREMATURE BABY 83 0.0028
556 HAEMODYNAMIC INSTABILITY 21 0.0028
557 METABOLIC DISORDER 16 0.0028
558 TREMOR 457 0.0028
559 GENERALISED OEDEMA 34 0.0027
560 SLUGGISHNESS 28 0.0027
561 MIOSIS 22 0.0027
562 HYPOMAGNESAEMIA 38 0.0027
563 FACE OEDEMA 46 0.0027
564 TUBULOINTERSTITIAL NEPHRITIS 51 0.0027
565 BLOOD THYROID STIMULATING HORMONE INCREASED 25 0.0027
566 SUPRAVENTRICULAR TACHYCARDIA 26 0.0027
567 DECUBITUS ULCER 22 0.0027
568 URINARY RETENTION 89 0.0027
569 PYELONEPHRITIS 23 0.0027
570 PANCYTOPENIA 146 0.0026
571 REFUSAL OF TREATMENT BY PATIENT 17 0.0026
572 FOOD ALLERGY 20 0.0026
573 CONJUNCTIVITIS 48 0.0026
574 PRODUCT ADMINISTRATION ERROR 52 0.0026
575 ARTERIOSCLEROSIS CORONARY ARTERY 17 0.0026
576 VITAMIN D DEFICIENCY 25 0.0026
577 EPSTEIN-BARR VIRUS INFECTION 16 0.0026
578 SLEEP DISORDER 180 0.0025
579 BREAST PAIN 27 0.0025
580 LOWER RESPIRATORY TRACT INFECTION 115 0.0025
581 GRAFT VERSUS HOST DISEASE 18 0.0025
582 BODY TEMPERATURE INCREASED 51 0.0025
583 RESPIRATORY DISORDER 74 0.0025
584 INCOHERENT 16 0.0025
585 OESOPHAGITIS 27 0.0025
586 PALLOR 67 0.0025
587 HEPATITIS ACUTE 16 0.0025
588 HEPATIC FAILURE 74 0.0025
589 LETHARGY 141 0.0024
590 ARTERIOSCLEROSIS 23 0.0024
591 BALANCE DISORDER 211 0.0024
592 BLOOD MAGNESIUM DECREASED 21 0.0024
593 HYPERCALCAEMIA 30 0.0024
594 FEEDING DISORDER 49 0.0024
595 DRUG-INDUCED LIVER INJURY 75 0.0024
596 DRUG USE DISORDER 20 0.0024
597 NO THERAPEUTIC RESPONSE 29 0.0024
598 HEMIPARESIS 40 0.0024
599 THROMBOTIC MICROANGIOPATHY 23 0.0024
600 GLOMERULAR FILTRATION RATE DECREASED 29 0.0024
601 DERMATITIS BULLOUS 17 0.0023
602 JAUNDICE 63 0.0023
603 ECCHYMOSIS 16 0.0023
604 GASTROENTERITIS 34 0.0023
605 WEIGHT INCREASED 521 0.0023
606 OXYGEN SATURATION DECREASED 130 0.0023
607 HYPERAESTHESIA 19 0.0023
608 SLEEP APNOEA SYNDROME 44 0.0023
609 ERECTILE DYSFUNCTION 59 0.0023
610 CARDIOMEGALY 28 0.0023
611 OVERDOSE 491 0.0023
612 EMOTIONAL DISORDER 70 0.0023
613 DISEASE RECURRENCE 108 0.0023
614 SHOCK 52 0.0023
615 PERSONALITY CHANGE 21 0.0023
616 RESPIRATORY RATE INCREASED 20 0.0023
617 HYPERBILIRUBINAEMIA 23 0.0022
618 SPLENOMEGALY 26 0.0022
619 PYREXIA 768 0.0022
620 VENTRICULAR EXTRASYSTOLES 23 0.0022
621 REBOUND EFFECT 25 0.0022
622 RENAL FAILURE CHRONIC 17 0.0022
623 PERICARDITIS 37 0.0022
624 RASH GENERALISED 57 0.0022
625 HEPATIC ENZYME INCREASED 150 0.0022
626 MULTIPLE ORGAN DYSFUNCTION SYNDROME 62 0.0022
627 RESPIRATORY TRACT INFECTION 57 0.0022
628 CHOLECYSTITIS 26 0.0022
629 DEAFNESS 57 0.0022
630 MUSCLE INJURY 18 0.0022
631 HYPERGLYCAEMIA 79 0.0022
632 HEMIPLEGIA 18 0.0022
633 MOOD ALTERED 59 0.0022
634 PERICARDIAL EFFUSION 50 0.0022
635 TARDIVE DYSKINESIA 61 0.0022
636 HYPOTENSION 431 0.0021
637 PURPURA 19 0.0021
638 CONTRAINDICATED PRODUCT ADMINISTERED 65 0.0021
639 HYPOGLYCAEMIA 104 0.0021
640 EJECTION FRACTION DECREASED 33 0.0021
641 BLOOD DISORDER 17 0.0021
642 PANCREATITIS 112 0.0021
643 HEAD INJURY 67 0.0021
644 HYPOPHAGIA 54 0.0021
645 RESPIRATORY FAILURE 154 0.0021
646 NEUROTOXICITY 37 0.0021
647 CARDIAC ARREST 174 0.0021
648 LIPASE INCREASED 16 0.0021
649 MEDICATION ERROR 116 0.0021
650 CHOLESTASIS 40 0.0021
651 RED BLOOD CELL SEDIMENTATION RATE INCREASED 23 0.0021
652 PERITONITIS 43 0.0021
653 BEDRIDDEN 27 0.0021
654 NERVOUS SYSTEM DISORDER 64 0.0020
655 LYMPHOPENIA 29 0.0020
656 PULMONARY CONGESTION 27 0.0020
657 LACTIC ACIDOSIS 66 0.0020
658 CEREBRAL INFARCTION 49 0.0020
659 VITAMIN D DECREASED 17 0.0020
660 MEMORY IMPAIRMENT 273 0.0020
661 DEPRESSED MOOD 105 0.0020
662 MUSCLE DISORDER 16 0.0020
663 BLOOD CREATININE INCREASED 127 0.0019
664 ESCHERICHIA INFECTION 16 0.0019
665 HYPERKALAEMIA 68 0.0019
666 BODY TEMPERATURE DECREASED 19 0.0019
667 DYSPHAGIA 183 0.0019
668 HYPERLIPIDAEMIA 23 0.0019
669 HALLUCINATION 145 0.0019
670 PRODUCT USE IN UNAPPROVED INDICATION 476 0.0019
671 HAEMOGLOBIN DECREASED 197 0.0019
672 EXPOSURE DURING PREGNANCY 119 0.0019
673 RENAL FAILURE ACUTE 81 0.0019
674 TYPE 2 DIABETES MELLITUS 64 0.0019
675 LIVER DISORDER 84 0.0019
676 LYMPHADENOPATHY 67 0.0019
677 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 18 0.0019
678 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 90 0.0019
679 SEPTIC SHOCK 81 0.0019
680 STOMATITIS 111 0.0018
681 SEPSIS 204 0.0018
682 SUBDURAL HAEMATOMA 26 0.0018
683 HAEMATEMESIS 46 0.0018
684 CONDITION AGGRAVATED 550 0.0018
685 ELECTROLYTE IMBALANCE 21 0.0018
686 VENTRICULAR FIBRILLATION 20 0.0018
687 HYPOCALCAEMIA 34 0.0018
688 GAIT DISTURBANCE 343 0.0018
689 THIRST 32 0.0018
690 POOR QUALITY SLEEP 38 0.0018
691 ANXIETY 489 0.0017
692 OBSTRUCTIVE AIRWAYS DISORDER 19 0.0017
693 VENTRICULAR TACHYCARDIA 28 0.0017
694 WITHDRAWAL SYNDROME 71 0.0017
695 BLOOD CALCIUM DECREASED 19 0.0017
696 ARRHYTHMIA 80 0.0017
697 MIGRAINE 161 0.0017
698 CYTOMEGALOVIRUS INFECTION 28 0.0017
699 DIABETES MELLITUS 127 0.0017
700 TREATMENT FAILURE 137 0.0017
701 HEPATITIS 42 0.0016
702 PRODUCT PRESCRIBING ERROR 39 0.0016
703 EYELID OEDEMA 19 0.0016
704 BONE MARROW FAILURE 33 0.0016
705 LIGAMENT SPRAIN 16 0.0016
706 INTERNATIONAL NORMALISED RATIO INCREASED 46 0.0016
707 PLEURAL EFFUSION 98 0.0016
708 MIDDLE INSOMNIA 30 0.0016
709 HYPERSOMNIA 46 0.0016
710 BLOOD POTASSIUM INCREASED 26 0.0016
711 CONSTIPATION 347 0.0016
712 PULMONARY OEDEMA 71 0.0016
713 GENERAL PHYSICAL HEALTH DETERIORATION 183 0.0016
714 SYNCOPE 158 0.0016
715 MICTURITION URGENCY 18 0.0016
716 INITIAL INSOMNIA 16 0.0016
717 ACCIDENTAL OVERDOSE 57 0.0016
718 CARDIO-RESPIRATORY ARREST 65 0.0016
719 BLOOD PRESSURE DECREASED 103 0.0015
720 THERAPY NON-RESPONDER 69 0.0015
721 PERIPHERAL COLDNESS 21 0.0015
722 MOUTH ULCERATION 32 0.0015
723 DEMENTIA 42 0.0015
724 SENSORY DISTURBANCE 24 0.0015
725 GASTROOESOPHAGEAL REFLUX DISEASE 120 0.0015
726 OEDEMA PERIPHERAL 181 0.0015
727 THERAPEUTIC RESPONSE DECREASED 90 0.0015
728 DECREASED ACTIVITY 16 0.0015
729 AMENORRHOEA 26 0.0015
730 RENAL IMPAIRMENT 124 0.0015
731 DEPRESSION 334 0.0015
732 MADAROSIS 17 0.0015
733 RASH ERYTHEMATOUS 70 0.0015
734 BLOOD CHOLESTEROL INCREASED 68 0.0015
735 HYPERTHYROIDISM 21 0.0014
736 INTENTIONAL PRODUCT MISUSE 126 0.0014
737 EYE DISORDER 47 0.0014
738 ACUTE RESPIRATORY DISTRESS SYNDROME 25 0.0014
739 OFF LABEL USE 1237 0.0014
740 VOMITING 663 0.0014
741 CHOLELITHIASIS 46 0.0014
742 VISUAL IMPAIRMENT 173 0.0014
743 PHOTOSENSITIVITY REACTION 23 0.0014
744 FALL 463 0.0014
745 BLISTER 78 0.0014
746 VISUAL ACUITY REDUCED 46 0.0014
747 RESTLESS LEGS SYNDROME 25 0.0014
748 HAND DEFORMITY 18 0.0014
749 PROTEINURIA 26 0.0014
750 HYPERTENSION 287 0.0014
751 MUSCLE ATROPHY 17 0.0013
752 QUALITY OF LIFE DECREASED 18 0.0013
753 AMNESIA 87 0.0013
754 NIGHTMARE 46 0.0013
755 PNEUMONIA 428 0.0013
756 HAEMATOMA 34 0.0013
757 DECREASED APPETITE 304 0.0013
758 INSOMNIA 348 0.0013
759 DYSSTASIA 38 0.0013
760 BRONCHITIS 96 0.0013
761 MENTAL STATUS CHANGES 36 0.0013
762 ABASIA 32 0.0013
763 HYPERHIDROSIS 166 0.0013
764 HEART RATE IRREGULAR 29 0.0013
765 IMMUNODEFICIENCY 19 0.0013
766 COLITIS 48 0.0013
767 CRYING 46 0.0013
768 FEAR 34 0.0013
769 VIRAL INFECTION 42 0.0013
770 DEEP VEIN THROMBOSIS 82 0.0013
771 FEELING JITTERY 24 0.0013
772 MOOD SWINGS 40 0.0013
773 OEDEMA 68 0.0013
774 DIABETIC KETOACIDOSIS 30 0.0012
775 METASTASES TO CENTRAL NERVOUS SYSTEM 16 0.0012
776 HIATUS HERNIA 16 0.0012
777 RESPIRATORY ARREST 34 0.0012
778 MOBILITY DECREASED 87 0.0012
779 PRODUCT USE ISSUE 227 0.0012
780 CEREBRAL HAEMORRHAGE 43 0.0012
781 HYPOAESTHESIA ORAL 18 0.0012
782 EAR PAIN 23 0.0012
783 DRUG INTOLERANCE 114 0.0012
784 ABDOMINAL PAIN 271 0.0012
785 RASH MACULAR 40 0.0011
786 MUSCULOSKELETAL STIFFNESS 100 0.0011
787 DYSPEPSIA 112 0.0011
788 HYPOACUSIS 49 0.0011
789 DRUG INEFFECTIVE 1498 0.0011
790 ANAEMIA 216 0.0011
791 DIABETES MELLITUS INADEQUATE CONTROL 20 0.0011
792 ASCITES 33 0.0011
793 ACUTE MYOCARDIAL INFARCTION 33 0.0011
794 OSTEOPOROSIS 46 0.0011
795 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 19 0.0011
796 GASTRITIS 29 0.0011
797 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 57 0.0011
798 HAEMATURIA 37 0.0011
799 HAEMOPTYSIS 30 0.0011
800 DEHYDRATION 143 0.0011
801 PREMATURE DELIVERY 17 0.0011
802 WEIGHT DECREASED 298 0.0011
803 FRACTURE 20 0.0011
804 GASTRIC ULCER 20 0.0011
805 SKIN DISORDER 35 0.0010
806 SKIN ULCER 27 0.0010
807 UNEVALUABLE EVENT 79 0.0010
808 ACUTE RESPIRATORY FAILURE 20 0.0010
809 NECK PAIN 58 0.0010
810 ACUTE KIDNEY INJURY 158 0.0010
811 MALAISE 448 0.0010
812 RIB FRACTURE 21 0.0010
813 ANGINA PECTORIS 29 0.0010
814 UPPER GASTROINTESTINAL HAEMORRHAGE 17 0.0010
815 URINARY TRACT INFECTION 172 0.0010
816 VERTIGO 61 0.0010
817 STAPHYLOCOCCAL INFECTION 33 0.0010
818 BLOOD PRESSURE FLUCTUATION 24 0.0010
819 HEART RATE INCREASED 99 0.0010
820 PNEUMONITIS 27 0.0010
821 INTERSTITIAL LUNG DISEASE 48 0.0010
822 ORAL PAIN 22 0.0010
823 RASH PAPULAR 22 0.0010
824 CHOKING 19 0.0010
825 ANGIOEDEMA 43 0.0010
826 CARDIAC FAILURE 78 0.0010
827 HEART RATE DECREASED 34 0.0010
828 COLD SWEAT 17 0.0010
829 LUNG DISORDER 47 0.0010
830 UPPER RESPIRATORY TRACT INFECTION 44 0.0010
831 WHEEZING 56 0.0009
832 RASH 406 0.0009
833 BLOOD PRESSURE SYSTOLIC INCREASED 18 0.0009
834 SWELLING FACE 60 0.0009
835 PRODUCT PRESCRIBING ISSUE 20 0.0009
836 CELLULITIS 46 0.0009
837 ASTHMA 103 0.0009
838 INFECTION 131 0.0009
839 GYNAECOMASTIA 28 0.0009
840 HEPATIC CIRRHOSIS 17 0.0009
841 LIP SWELLING 30 0.0009
842 PREGNANCY 18 0.0009
843 SKIN LESION 24 0.0009
844 DYSURIA 32 0.0009
845 PRESYNCOPE 21 0.0009
846 INTENTIONAL DRUG MISUSE 18 0.0009
847 FEBRILE NEUTROPENIA 57 0.0009
848 PULMONARY EMBOLISM 81 0.0009
849 DIARRHOEA 545 0.0008
850 MUSCULOSKELETAL DISORDER 16 0.0008
851 ERYTHEMA 172 0.0008
852 RENAL FAILURE 110 0.0008
853 PALPITATIONS 96 0.0008
854 ASTHENIA 307 0.0008
855 CHEST PAIN 151 0.0008
856 ANAPHYLACTIC SHOCK 21 0.0008
857 NASOPHARYNGITIS 148 0.0008
858 COMPLETED SUICIDE 66 0.0008
859 POLLAKIURIA 33 0.0008
860 DIZZINESS 393 0.0008
861 DRUG WITHDRAWAL SYNDROME 69 0.0008
862 LUNG NEOPLASM MALIGNANT 32 0.0008
863 TOOTH DISORDER 17 0.0008
864 RENAL DISORDER 35 0.0008
865 FUNGAL INFECTION 25 0.0007
866 BLOOD PRESSURE INCREASED 113 0.0007
867 PHARMACEUTICAL PRODUCT COMPLAINT 19 0.0007
868 INTENTIONAL PRODUCT USE ISSUE 64 0.0007
869 ILL-DEFINED DISORDER 44 0.0007
870 MUSCULAR WEAKNESS 82 0.0007
871 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 21 0.0007
872 FEMUR FRACTURE 22 0.0007
873 CHROMATURIA 16 0.0007
874 NERVOUSNESS 37 0.0007
875 VISION BLURRED 97 0.0007
876 SWOLLEN TONGUE 22 0.0007
877 CORONARY ARTERY DISEASE 21 0.0007
878 PRODUCTIVE COUGH 33 0.0007
879 BLINDNESS 28 0.0007
880 PANIC ATTACK 25 0.0007
881 RECTAL HAEMORRHAGE 29 0.0007
882 DYSPNOEA 382 0.0007
883 NAUSEA 529 0.0007
884 PARAESTHESIA 105 0.0007
885 ALOPECIA 131 0.0007
886 FATIGUE 509 0.0007
887 CARDIAC DISORDER 61 0.0007
888 COUGH 182 0.0006
889 ABDOMINAL DISTENSION 67 0.0006
890 MYELOSUPPRESSION 23 0.0006
891 GLYCOSYLATED HAEMOGLOBIN INCREASED 16 0.0006
892 FREQUENT BOWEL MOVEMENTS 17 0.0006
893 RASH PRURITIC 34 0.0006
894 OROPHARYNGEAL PAIN 58 0.0006
895 ABNORMAL DREAMS 17 0.0006
896 HEADACHE 384 0.0006
897 FEELING COLD 17 0.0006
898 BLOOD POTASSIUM DECREASED 18 0.0006
899 BACK PAIN 138 0.0006
900 ECZEMA 31 0.0006
901 NEPHROLITHIASIS 27 0.0006
902 EYE PAIN 33 0.0006
903 DIVERTICULITIS 16 0.0006
904 PRODUCT SUBSTITUTION ISSUE 33 0.0006
905 FEELING ABNORMAL 137 0.0006
906 DRY MOUTH 46 0.0006
907 ATRIAL FIBRILLATION 55 0.0006
908 GASTROINTESTINAL HAEMORRHAGE 47 0.0006
909 UNDERDOSE 41 0.0006
910 INFLUENZA LIKE ILLNESS 46 0.0006
911 COVID-19 98 0.0006
912 GASTROINTESTINAL DISORDER 50 0.0006
913 SKIN EXFOLIATION 47 0.0006
914 ROAD TRAFFIC ACCIDENT 23 0.0005
915 EPISTAXIS 41 0.0005
916 OCULAR HYPERAEMIA 26 0.0005
917 HOSPITALISATION 84 0.0005
918 DRY EYE 27 0.0005
919 HYPERSENSITIVITY 99 0.0005
920 CHILLS 62 0.0005
921 HAEMATOCHEZIA 29 0.0005
922 CHEST DISCOMFORT 52 0.0005
923 SYSTEMIC LUPUS ERYTHEMATOSUS 18 0.0005
924 INFLAMMATION 26 0.0005
925 CYSTITIS 16 0.0005
926 DRUG EFFECT DECREASED 27 0.0005
927 DYSPHONIA 29 0.0005
928 THERAPEUTIC PRODUCT EFFECT DECREASED 22 0.0005
929 DRUG DEPENDENCE 77 0.0005
930 GAIT INABILITY 16 0.0005
931 DYSPNOEA EXERTIONAL 18 0.0005
932 MYOCARDIAL INFARCTION 83 0.0005
933 PRURITUS 182 0.0005
934 HAEMORRHAGE 48 0.0005
935 TINNITUS 21 0.0005
936 INFUSION RELATED REACTION 30 0.0005
937 DISEASE PROGRESSION 53 0.0004
938 ADVERSE EVENT 41 0.0004
939 FLUSHING 45 0.0004
940 NASAL CONGESTION 26 0.0004
941 INJURY 31 0.0004
942 ABDOMINAL PAIN UPPER 90 0.0004
943 ANAPHYLACTIC REACTION 24 0.0004
944 THERAPY CESSATION 22 0.0004
945 BURNING SENSATION 30 0.0004
946 SWELLING 40 0.0004
947 CONTUSION 40 0.0004
948 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 73 0.0004
949 URTICARIA 67 0.0004
950 SKIN DISCOLOURATION 18 0.0004
951 BLOOD GLUCOSE INCREASED 73 0.0004
952 CATARACT 23 0.0004
953 PAIN 235 0.0004
954 HYPOAESTHESIA 57 0.0004
955 DISCOMFORT 23 0.0004
956 MUSCLE SPASMS 69 0.0004
957 PAIN IN EXTREMITY 109 0.0004
958 ABDOMINAL DISCOMFORT 62 0.0004
959 INFLUENZA 41 0.0004
960 HERPES ZOSTER 21 0.0004
961 EYE IRRITATION 21 0.0004
962 CEREBROVASCULAR ACCIDENT 61 0.0004
963 ARTHROPATHY 20 0.0004
964 MULTIPLE SCLEROSIS 17 0.0004
965 FLUID RETENTION 18 0.0004
966 PSORIASIS 46 0.0004
967 ADVERSE DRUG REACTION 31 0.0003
968 FEELING HOT 21 0.0003
969 SURGERY 20 0.0003
970 MYALGIA 58 0.0003
971 RHINORRHOEA 21 0.0003
972 INCORRECT DOSE ADMINISTERED 70 0.0003
973 EMOTIONAL DISTRESS 37 0.0003
974 ACNE 23 0.0003
975 DEATH 246 0.0003
976 FLATULENCE 16 0.0003
977 ILLNESS 29 0.0003
978 CHRONIC KIDNEY DISEASE 21 0.0003
979 SINUSITIS 28 0.0003
980 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 55 0.0003
981 ARTHRALGIA 110 0.0003
982 DYSGEUSIA 19 0.0003
983 NEOPLASM MALIGNANT 17 0.0003
984 MALIGNANT NEOPLASM PROGRESSION 26 0.0003
985 THERAPY INTERRUPTED 18 0.0003
986 ACCIDENTAL EXPOSURE TO PRODUCT 25 0.0002
987 JOINT SWELLING 28 0.0002
988 PRODUCT DOSE OMISSION ISSUE 66 0.0002
989 NEUROPATHY PERIPHERAL 21 0.0002
990 HOT FLUSH 16 0.0002
991 DRY SKIN 26 0.0002
992 BREAST CANCER 17 0.0002
993 PERIPHERAL SWELLING 28 0.0002
994 PRODUCT QUALITY ISSUE 21 0.0002
995 NO ADVERSE EVENT 18 0.0001